2630.HK (Vigonvita Life Sciences Co., Ltd.) is a recent IPO.
It began trading on November 6, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
2630.HK·
Vigonvita Life Sciences Co., Ltd.
HKSE·Drug Manufacturers, General · Healthcare
HK$94.00HK$1.10−1.16%
Market capHK$15.69B·Market closed·Sep 7 8:08 AM UTC
Loading…
Frequently Asked Questions About 2630.HK
Where can I find news about 2630.HK?
The latest headlines, third-party analysis, and SEC filings for Vigonvita Life Sciences Co., Ltd. (2630.HK) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are 2630.HK's SEC filings?
Vigonvita Life Sciences Co., Ltd. (2630.HK)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are 2630.HK's earnings call transcripts?
Full earnings call transcripts for Vigonvita Life Sciences Co., Ltd. (2630.HK) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.
